Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes

J Exp Med. 1988 Aug 1;168(2):751-9. doi: 10.1084/jem.168.2.751.

Abstract

Human rTNF/Cachectin was shown to stimulate gene transcription of plasminogen activator inhibitor (PA1)-1 and PAI-2, and simultaneously suppress constitutive gene expression of tissue-type plasminogen activator (t-PA) in human fibrosarcoma cells. We propose that a TNF-mediated reprogramming of gene transcription induces, in appropriate target cells, an anti-fibrinolytic state, which may cooperate with the induction of procoagulant activity (tissue factor) to stabilize the fibrin deposits commonly found in inflamed tissue. PAI genes also provide a model system for a study of the molecular pathways underlying TNF-mediated signal transduction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cloning, Molecular
  • Fibrosarcoma
  • Genes* / drug effects
  • Glycoproteins / genetics*
  • Humans
  • Plasminogen Activators / antagonists & inhibitors
  • Plasminogen Inactivators
  • Recombinant Proteins / pharmacology
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Glycoproteins
  • Plasminogen Inactivators
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Plasminogen Activators